A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

Eli Lilly (LLY) saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to ...

The company already has injectable GLP-1 drugs that are generating billions in revenue, Despite its valuation, the stock only ...

Eli Lilly's approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Eli Lilly plans to build a massive $5.9 billion campus that could change the landscape of Northeast Houston’s Generation Park ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

Apple (NASDAQ: AAPL) and Eli Lilly (NYSE: LLY) share several similarities. Both are long-standing leaders in their respective ...

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh ...

The restructuring marks the first major action authorised by new CEO Mike Doustdar in a bid to turn the company’s fortunes ...